Medication Costs for Dofetilide: Comparison of Insurance Copayments Versus Generic Pricing Through Cost Plus Drug Company
Circulation · 17.03.2026 · 153 (11) · 868-870
DOI: 10.1161/circulationaha.125.076745 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation, erschienen am 17.03.2026. Verfasst von Godefroy Chery und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cardiac Electrophysiology Section, University of Pennsylvania School of Medicine, Philadelphia. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Cardiac Electrophysiology Section, University of Pennsylvania School of Medicine, Philadelphia.
ORCID-Profile: Andres Enriquez, Rajat Deo, Saman Nazarian, David J Callans, David S Frankel, Francis E Marchlinski, Timothy M Markman
Zitieren
APA
Chery, G., Every, A., Enriquez, A., Deo, R., Nazarian, S., Callans, D. J., Frankel, D. S., Marchlinski, F. E., & Markman, T. M. (2026). Medication Costs for Dofetilide: Comparison of Insurance Copayments Versus Generic Pricing Through Cost Plus Drug Company. Circulation, 153(11), 868-870. https://doi.org/10.1161/circulationaha.125.076745
Vancouver
Chery G, Every A, Enriquez A, Deo R, Nazarian S, Callans DJ, et al. Medication Costs for Dofetilide: Comparison of Insurance Copayments Versus Generic Pricing Through Cost Plus Drug Company. Circulation. 2026;153(11):868-870. doi:10.1161/circulationaha.125.076745
BibTeX
@article{Chery2026,
author = {Chery, Godefroy and Every, Amanda and Enriquez, Andres and Deo, Rajat and Nazarian, Saman and Callans, David J and Frankel, David S and Marchlinski, Francis E and Markman, Timothy M},
title = {Medication Costs for Dofetilide: Comparison of Insurance Copayments Versus Generic Pricing Through Cost Plus Drug Company},
journal = {Circulation},
year = {2026},
volume = {153},
number = {11},
pages = {868--870},
doi = {10.1161/circulationaha.125.076745}
}
EUVIMED